Panacea Acquisition Corp. II

Panacea Acquisition Corp. II (Nasdaq: PANA) is a blank-check company formed to pursue a merger or acquisition in the healthcare and life sciences sector, with a particular emphasis on biopharma and medical technology. Sponsored by Panacea Capital Group, LLC, the company completed its initial public offering in 2021. On February 7, 2022, PANA filed a Form 10-Q/A — an amendment to a previously submitted quarterly report — with the Securities and Exchange Commission under accession number 0001213900-22-005707. At the time of that filing, the company remained in its search phase for a suitable business combination target. Sign up at SpacDesk for complete filing histories, sponsor profiles, and deal analytics on PANA and the broader SPAC market.